Benson Investment Management Company, Inc. Bristol Myers Squibb CO Transaction History

Benson Investment Management Company, Inc.

$247 Million
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 04, 2018	SELL	$55.19 - $62.25 $2.32 Million - $2.62 Million	-42,020 Closed	0 $0
Q1 2018 Apr 06, 2018	BUY	$59.92 - $68.98 $23,368 - $26,902	390 Added 0.94%	42,020 $2.66 Million
Q4 2017 Jan 12, 2018	BUY	$59.94 - $65.35 $8,091 - $8,822	135 Added 0.33%	41,630 $2.55 Million
Q3 2017 Oct 16, 2017	BUY	$55.23 - $63.74 $2.29 Million - $2.64 Million	41,495	41,495 $2.65 Million

Others Institutions Holding BMY

# of Institutions

2,454

Shares Held

1.5B

Call Options Held

29.6M

Put Options Held

32.1M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$10.3 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.77 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$5.06 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$4.13 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.26 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $118B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Benson Investment Management Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Benson Investment Management Company, Inc. with notifications on news.

Account